CIROFEM-D3 Oral Solution
CIROFEM-D3 is a ready-to-drink Vitamin D3 Oral Solution I.P. containing 60,000 I.U. of cholecalciferol per 5 ml bottle. Presented in a convenient 4 x 5 ml bottle pack, it ensures precise dosing and rapid improvement of Vitamin D3 levels. Indicated for the prevention and treatment of Vitamin D deficiency, osteoporosis, rickets, and osteomalacia. Manufactured by BAGRX PHARMACEUTICALS, CIROFEM-D3 offers high bioavailability, excellent tolerability, and patient-friendly ready-to-use format.
You must be logged in to post a review.
Related products
DYDROBIG Tablets
STOP-CR-15 Tablets
BAGSURE-500 Injection
SPIRABAG™ Tablets
-
Contains Spiramycin Tablets I.P. 3 M.I.U. (3 Million I.U.) , a macrolide antibiotic with potent anti-infective and antiparasitic activity
-
Provides high tissue penetration and prolonged post-antibiotic effect
-
Each pack contains 10 x 1 x 10 tablets (100 tablets total) , ideal for complete treatment courses
-
Indicated for toxoplasmosis (including in pregnancy), respiratory tract infections, oral infections, and STIs
-
Well-suited for prophylaxis and treatment of congenital toxoplasmosis
-
Generally well-tolerated with low risk of drug interactions
-
Manufactured by BAGRX PHARMACEUTICALS under the SPIRABAG™ brand
Nitrofem Tablets
-
Contains Nitrofurantoin Sustained Release Tablets I.P. 100 mg, a urinary tract-specific antibacterial agent
-
Sustained release formulation ensures prolonged drug action and reduced dosing frequency
-
Each pack contains 10 x 10 tablets (100 tablets total) for extended treatment course and better compliance
-
Indicated for treatment and prevention of acute and recurrent uncomplicated urinary tract infections (UTIs)
-
Effective against susceptible gram-positive and gram-negative uropathogens including E. coli, Klebsiella, and Enterococcus
-
Achieves high urinary concentration with minimal systemic accumulation
-
Manufactured by FEMiNA under stringent quality standards

Reviews
There are no reviews yet.